Ipilimumab/Nivolumab

Reactions Weekly 2026

View at publisher

DOI: 10.1007/s40278-026-92111-4

Cited by: 0

References: 1

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Pharmacovigilance and Adverse Drug Reactions T-cell and B-cell Immunology

References 1